Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Pharmacological and Toxicological Methods|May 3, 2006
A model of orthostatic hypotension in the conscious monkey using lower body negative pressureDennis J Murphy, Jonathan P Renninger, Haisong JuFrontiers in Pharmacology|February 4, 2012
Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical EvaluationGül Erdemli, Albert M Kim, Haisong Ju, et al.Current Opinion in Investigational Drugs (London, England : 2000)|October 30, 2003
p38 mitogen-activated protein kinase inhibitors for the treatment of chronic cardiovascular diseaseThomas M Behr, Marinela Berova, Christopher P Doe, et al.Journal of Pharmacological and Toxicological Methods|October 3, 2015
Translational assessment of cardiac contractility by echocardiography in the telemetered ratHai-Ming Tang, Haisong Ju, Shufang Zhao, et al.Heart Rhythm|June 20, 2012
Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: a blinded validationTengxian Liu, Martin Traebert, Haisong Ju, et al.The Journal of Pharmacology and Experimental Therapeutics|October 17, 2003
p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertensionHaisong Ju, David J Behm, Sandyha Nerurkar, et al.Molecular and Cellular Biochemistry|August 10, 2006
Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cellsNambi Aiyar, Jyoti Disa, Zhaohui Ao, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|June 4, 2016
Histone Deacetylase Inhibitors Prolong Cardiac Repolarization through Transcriptional MechanismsStan Spence, Mark Deurinck, Haisong Ju, et al.American Journal of Physiology. Heart and Circulatory Physiology|February 9, 2002
Acute protection of ischemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase CZhi-Sheng Jiang, Raymond R Padua, Haisong Ju, et al.The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Sustained activation of p38 mitogen-activated protein kinase contributes to the vascular response to injuryHaisong Ju, Sandhya Nerurkar, Charles F Sauermelch, et al.Pageof 2